Clinical Characteristics and Prognosis of Osteoclast-like Giant Cell Tumors of the Pancreas Compared with Pancreatic Adenocarcinomas: A Population-Based Study

Mingfang Xu; Wei Chen; Dong Wang; Mao Nie

doi:10.12659/MSM.922585

27 July 2020 : Clinical Research

Clinical Characteristics and Prognosis of Osteoclast-like Giant Cell Tumors of the Pancreas Compared with Pancreatic Adenocarcinomas: A Population-Based Study

Mingfang Xu^1ABCDE, Wei Chen^2ABCD, Dong Wang^1ABCD, Mao Nie^3EFG*

DOI: 10.12659/MSM.922585

Med Sci Monit 2020; 26:e922585

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Kaplan-Meier curves indicated that the mOS of OGTP patients with localized, regional, and distant staging were 73, 26, and 7 months, respectively (P<0.01). mOS – median overall survival; OGTP – osteoclast-like giant cell tumor of the pancreas.

Back to the Article

Clinical Characteristics and Prognosis of Osteoclast-like Giant Cell Tumors of the Pancreas Compared with Pancreatic Adenocarcinomas: A Population-Based Study

Your Privacy